BrainsWay Reports Third Quarter 2026 Financial Results and Operational Highlights
Globe Newswire•10/11/2026•07:30 ET
0
Key Highlights
- ➤Q3 revenue $18.1 million, up 34% year-over-year
- ➤Q3 operating income $2.6 million, up 107% year-over-year
- ➤Shipped 130 Deep TMS systems, up 44% year-over-year
- ➤RPOs reached approximately $85 million, up 31% year-over-year
- ➤Full-year 2026 results expected at guidance’s upper end, potentially modestly exceeding it
Expert Statements
Hadar Levy, Chief Executive Officer of BrainsWay
“Our third-quarter results demonstrate our ability to translate strong revenue growth into higher profitability and cash generation. Revenue increased 34%, while operating income grew 107% and operating cash flow reached $6.2 million”
Hadar Levy, Chief Executive Officer of BrainsWay
“Our performance reflects the strength of our business model, growing adoption of Deep TMS, and continued momentum in recurring revenue and operating leverage.”
Hadar Levy, Chief Executive Officer of BrainsWay
“Looking ahead, we see significant opportunities to accelerate growth through broader reimbursement coverage initiatives, increased utilization across our expanding installed base, and the introduction of innovative treatment protocols.”
Hadar Levy, Chief Executive Officer of BrainsWay
“At the same time, we are strengthening our market position through strategic partnerships with leading healthcare providers, expanding our clinical evidence, and opening new pathways for patients to access our technology.”
Hadar Levy, Chief Executive Officer of BrainsWay
“We believe these initiatives position BrainsWay for sustained growth, increasing profitability, and long-term value creation”
Revenue increased 34% to $18.1 million in Q3 2026; Operating income rose 107% to $2.6 million and Adjusted EBITDA rose approximately 92% to $3.9 million
Remaining performance obligations grew 31% year-over-year to approximately $85 million
Get started
Create a free account to read the full story.